Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Somatostatin receptor scintigraphy of malignant lymphoma--current status.

× No keyword cloud information.

13 in total

1. Somatostatin receptor scintigraphy in the staging of lymphomas.

Authors: V Ivancević; B Wörmann; C Nauck; D Sandrock; D L Munz; W Hiddemann; D Emrich
Journal: Leuk Lymphoma Date: 1997-06

2. Somatostatin receptors on human lymphocytes and leukaemia cells.

Authors: K Hiruma; T Koike; H Nakamura; T Sumida; T Maeda; H Tomioka; S Yoshida; T Fujita
Journal: Immunology Date: 1990-12 Impact factor: 7.397

3. Somatostatin receptor-based imaging in malignant lymphomas.

Authors: J P O'Brien
Journal: J Nucl Med Date: 1995-01 Impact factor: 10.057

4. Somatostatin analogue scintigraphy of malignant lymphomas.

Authors: P M Vanhagen; E P Krenning; J C Reubi; A H Mulder; W H Bakker; H Y Oei; B Löwenberg; S W Lamberts
Journal: Br J Haematol Date: 1993-01 Impact factor: 6.998

Review 5. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications.

Authors: J C Reubi; J Laissue; E Krenning; S W Lamberts
Journal: J Steroid Biochem Mol Biol Date: 1992-09 Impact factor: 4.292

6. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.

Authors: R Bares; P Galonska; W Dempke; S Handt; U Büll; R Osieka
Journal: Horm Metab Res Suppl Date: 1993

7. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.

Authors: J C Reubi; B Waser; M van Hagen; S W Lamberts; E P Krenning; J O Gebbers; J A Laissue
Journal: Int J Cancer Date: 1992-04-01 Impact factor: 7.396

8. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

Authors: A M Stanisz; D Befus; J Bienenstock
Journal: J Immunol Date: 1986-01 Impact factor: 5.422

9. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.

Authors: R W Lipp; H Silly; G Ranner; H Dobnig; A Passath; G Leb; G J Krejs
Journal: J Nucl Med Date: 1995-01 Impact factor: 10.057

10. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.

Authors: T E Witzig; L Letendre; J Gerstner; G Schroeder; J A Mailliard; G Colon-Otero; R F Marschke; H E Windschitl
Journal: J Clin Oncol Date: 1995-08 Impact factor: 44.544